Life Sciences Product Launch & Commercialization Services
Despite massive spending, around two-thirds of product launches today fail to meet commercial expectations. As rising R&D expenditures continue to increase competition and clinical trial delays compress patent protection, commercial teams are challenged to design and execute integrated and aligned programs that capitalize on each product opportunity.
CREO works collaboratively with life sciences leaders and their teams to intimately refine and intertwine strategy and execution. Our commercialization leaders have decades of experience successfully developing and launching numerous life sciences products across multiple therapeutic areas, organizational sizes, and operating models.
The New Commercialization Paradigm
The life sciences market space is highly dynamic: competitors are advancing, regulatory postures are evolving, market access is shifting, and new commercial learnings are emerging. In the face of such continuous change, commercialization strategies can quickly become outdated. Launch strategy and launch execution must now be intimately intertwined, continually refined, and pulled back through to the operational plan to optimize your product’s trajectory.
Right-Sized, Integrated Support from CREO
From clinical trials through post-launch, CREO offers solutions for the most critically important milestones. CREO’s engagement models are highly flexible, addressing the most critical elements of commercial growth for your product. Our adaptive staffing model enables skill sets to be phased in and out to match dynamic needs, dialing up or down support as needed and offering better use of your budget. And CREO’s unique, cross-functional approach to product launch and commercialization offers an integrated, iterative approach to optimizing market traction and commercial performance.
How We Help Clients
Product Launch Strategy
The industry forces shaping life sciences commercialization– longer timetables, more complex research, higher regulatory scrutiny, record new product entries, and evolving reimbursement – have produced new requirements for optimizing product launches. On-the-ground experiences with launch execution – commercial successes, emerging barriers, unanticipated gaps, and more – provide critical insights needed to inform and shape the strategy for stronger market adoption. Capitalizing on each commercial opportunity necessitates a modernized approach to life sciences commercialization which is iterative and dynamic. Organizations must strongly orchestrate the right leadership, experience, and capabilities to achieve their goals.
CREO’s product launch and commercialization experts serve as your advisors on strategy and your teammates on execution. Our unique Launch Strategy Office (LSO) accelerates your strategic journey by leveraging cross-industry perspectives and generating consensus through our alignment and refinement framework. Our team leverages its experience successfully developing and launching life sciences products across multiple therapeutic areas and operating models to provide value in the following areas:
Market Shaping
Gaining perspectives on the intended market and leveraging your strengths to maximize market traction.
Pricing & Market Access
Ensuring payers are engaged early and are educated on the product and its unique value.
Competitive Strategy Development
Creating space for your product to succeed in the marketplace at launch and beyond.
Product Launch Coordination and Management
CREO goes beyond templates and frameworks – our co-pilots drive your outcomes.
CREO partners with your product and commercialization teams to a) establish your cross-enterprise launch team, b) align on the tactical plan that best delivers your strategy, and c) orchestrate the ongoing execution of the plan.
Through our unique Launch Management Office (LMO), CREO provides operational support services to help organizations prepare the right capabilities, flexibly scale capacity, and accurately assess commercial performance.
Our team seamlessly infuses program, project, and change management methodologies to drive excellence in operations and delivery. CREO’s cross-functional, scalable solutions support the entire product journey with services such as:
Launch Steering
Leveraging a holistic partnership that blends program and change management with experience from driving launches at other organizations.
Readiness Assessment
Looking across people, process, and tools, as well as key launch health metrics, to understand how well prepared your organization is to launch.
Capability Design & Implementation
Applying right-sized solutions to optimize operating models & ways of working, unlocking your teams’ full potential.
Launch Milestones Execution
Any product launch reflects a major growth point for any life sciences company. Organizations typically have a lot to do to rapidly scale up operations and effectively execute on the critical tasks needed to position themselves for the best commercial outcomes.
CREO’s life sciences commercialization experts have the proven experience to sprint through critical milestones from trials through launch. Our product launch and commercialization experts drive outcomes at each step of the launch journey across regulatory, scientific, commercialization, and operational efforts.
Through this process, we address growth areas, such as:
Clinical Development Support
Driving clinical trial-related activities ranging from CRO assessment & selection, clinical systems & data management, operational scaling, and optimization.
Regulatory Enablement
Assisting teams with FDA and other regulatory authority submissions, responses, ongoing management, and readiness activities such as mock inspections.
Commercial and Operations Scale-up
Supporting organizations as they ramp towards launch readiness, addressing critical growth issues such as benchmarking, insights generation, marketing milestones, commercial systems and data, and life cycle management.
Karna needed to be more responsive to change. CREO brought a methodology that allowed Karna leadership to identify and focus on the fewest, most important things.
– Wayne M. Karna
Our People
Bob Riefer
Managing Director
Bob’s well-rounded background began 25+ years ago on the industry side where he gained firsthand experience in multiple sectors, and across a host of…
Akira Robinson
Managing Director
Akira is a passionate consultant, bringing 20 years of experience serving clients exclusively in the life sciences industry across the US, Europe, and Asia.
Noah Rosenberg
Director
Noah is an experienced strategist, well versed in bringing strategic insight to practical application that can implemented in the real world.
Get the White Paper
Successful product launches, especially in global markets, require significant financial investments. To maximize returns, launch budgets should be treated as investments rather than simple operating expenses. Discover how life sciences companies can turn product launches into high-yield investments by adopting a strategic, investor-driven approach.
Discover the four-step framework that ensures every dollar invested in your launch strategy drives maximum impact. Download the white paper today.
Five Reasons Your M365 Configuration May Not Be Secure
Microsoft 365 (M365) is a powerful suite of productivity tools that has become widely adopted in life sciences organizations globally. As…
Closing the Strategy-Execution Gap in Product Launches
A few years ago, an article in the Harvard Business Review caught my eye with the analysis that only 8% of…
Growth-Stage Life Sciences Companies Need CRM Now, Not Later
Periods of rapid growth can leave life sciences, healthcare, and pharma companies feeling like they are building a plane while already…
Why Life Science Companies Need a Different Kind of Technology Partner
Learn how a different kind of technology partner can provide growth-stage life sciences companies the adaptable, compliant IT solutions they need…
In The Wake: Four Implications of the Health Care Cybersecurity Improvement Act of 2024
Learn about the four key implications of the Health Care Cybersecurity Improvement Act of 2024.
Challenges and Opportunities for CDMOs and CROs in 2024
The pharmaceutical market is changing rapidly, and the firms that serve the pharma market, including contract development and manufacturing organizations (CDMOs)…
We’re ready to help.
Need clarity on actions to reach the next level of growth?
Don’t wait to connect with CREO.